Italy· 050355015
LUPKYNIS*180 cps molli 7,9 mg
A voclosporin product containing voclosporina, registered in Italy by OTSUKA PHARMACEUT.NETHER.BV, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Voclosporin is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AD03 (voclosporin), each read from that country’s own register.
- This record: Italy
- 9 of them publish a price we can compare per daily dose
Voclosporin · ATC L04AD03
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of voclosporin costs, country by country.
Normalised to the WHO defined daily dose (47.4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Voclosporin · price per daily dose (47.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$30.96
The record
At a glance
- Active substance
- Voclosporina
- Manufacturer
- OTSUKA PHARMACEUT.NETHER.BV
- Country
- Italy (IT)
- ATC code
- L04AD03
- ATC class
- Voclosporin
- Defined daily dose
- 47.4 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic050355015LUPKYNIS*180 cps molli 7,9 mgEUR 1801.3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Voclosporin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLUPKYNISOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- United StatesLUPKYNISAurinia Pharma U.S., Inc.
- SpainLUPKYNIS 7,9 MG CAPSULAS BLANDASOtsuka Pharmaceutical Netherlands B.V.
- FinlandLupkynisOtsuka Pharmaceutical Netherlands B.V.
- United KingdomLupkynis 7.9mg capsulesOtsuka Pharmaceuticals (U.K.) Ltd
- BelgiumLupkynis 7.9 mgOtsuka Pharmaceutical Netherlands
- IcelandLupkynisOtsuka Pharmaceutical Netherlands B.V.*
- NetherlandsLupkynis 7,9 mg, zachte capsulesOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Lupkynis
- Liechtenstein · Lupkynis
- Norway · Lupkynis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4445ac3a-df00-4931-b911-fab5339618b5 GET /v1/drugs/4445ac3a-df00-4931-b911-fab5339618b5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 1801.3,
"source": "aifa",
"currency": "EUR",
"strength": "VOCLOSPORINA 7,9MG 180 UNITA' USO ORALE",
"substance": "Voclosporina",
"equivalence_group": "MMO",
"transparency_flag": null
}See everything about voclosporin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.